VisionAid, a pioneer in eye health technology, took center stage at the Congressional Briefing held last September 20 and 21, 2023, in Washington, DC. Hosted by the Alliance for Eye and Vision Research (AEVR) and the American Macular Degeneration Foundation (AMDF), the event advocates for increased funding for the National Institutes of Health and the National Eye Institute (NEI) to advance vision research and improve patient care. The potential financial impact is undeniable, with vision problems projected to impose an annual U.S. cost burden of $717 billion by 2050.
During the two-day event, VisionAid showcased the remarkable capabilities of its state-of-the-art Eye Disease Simulator. This innovation allowed attendees, including congressional representatives, researchers, and staffers, to gain firsthand experience of the challenges faced by individuals with various eye diseases. It provided insights into the impact of vision loss on daily life and emphasized the need for continued investments in eye health research.
VisionAid Founders Dylan Stroud and Taylor Speegle stated, “Seeing policymakers experience the world through the eyes of those with visual impairments and deepening their understanding fuels our mission to advance vision research and improve patient care globally.”
Beyond Capital Hill, VisionAid’s Eye Disease Simulator is emerging as an indispensable tool in eye care. By fostering understanding and empathy, it equips optometrists and ophthalmologists to run not only more effective but also more profitable practices. By bolstering patient education, it ensures consistent follow-ups, rigorous adherence to recommendations, and timely interventions — all rooted in a patient’s deep grasp of their disease’s gravity. Already adopted by institutions like MIT, Roseman University, AMDF, and AEVR, this advanced simulation tool is proving invaluable in research, education, advocacy, and outreach. Beyond clinics, its application has extended into areas such as elderly care, vocational rehab, and even architectural design, cementing its transformative role in creating a more inclusive world for those living with eye disease.
To learn more about VisionAid’s Eye Disease Simulator, please visit https://www.visionaid.io/eye-disease-simulator.
Media ContactCompany Name: VisionAidContact Person: Dylan StroudEmail: Send EmailPhone: 702-582-7863Country: United StatesWebsite: https://www.visionaid.io/eye-disease-simulator
